Free tool
Cell therapy stocks
We cover 9 companies grouped under the Cell therapy theme. The median market value in the group is $291.63M. Across the group, the median move over the past trading day is +0.59%. Price change over the past year runs from −48.9% to +17.1% across the middle 80 percent of the group, with a median of −32.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | −3.82% |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −55.90% |
| 005690.KS | Pharmicell Co., Ltd. | $472.35M | Small cap | +1.56% |
| 219A.T | HEARTSEED INC | $338.82M | Small cap | −32.33% |
| 4894.T | Cuorips Inc. | $291.63M | Small cap | −19.00% |
| 4593.T | Healios K.K. | $239.21M | Small cap | −40.92% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | $223.27M | Small cap | +79.30% |
| 504A.T | Innovacell Inc. | $156.32M | Small cap | −47.14% |
| OCC.AX | Orthocell Limited | $152.21M | Small cap | −35.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.